COMy - The 8th world Congress on Controversies in multiple Myeloma

Le COMy se tiendra du 12 au 15 mai 2022 à Paris

David Sourdive, PhD, EVP CMC and Manufacturing, Roman Galetto,PhD, Director, Preclinical and Program Management & Katie Newhall, PhD, Vice President Translational Sciences présenteront le 14 mai à 8h30 (heure française) : "Innovation for Patients with Relapsed/Refractory Multiple Myeloma: Development of TALEN gene-edited Allogeneic CAR-T Therapies Targeting CS1."

Pour s'inscrire, cliquez ici :  https://comylive.cme-congresses.com/registration/